Halozyme to Participate in Upcoming Investor Conferences

SAN DIEGO, Nov. 9, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that members of its management team are scheduled to present and host investor meetings at the following investor conferences: Event: J.P. Morgan Equity Opportunities Forum…

Click here to view original post